Journal of Neural Transmission

, Volume 115, Issue 4, pp 625–630 | Cite as

Evidence for the effectiveness of botulinum toxin for spasmodic dysphonia from high-quality research designs



The practice of evidence-based medicine promotes use of the knowledge ascertained from high quality research designs. The objective of this review was to determine what evidence has been provided from high quality research designs (e.g., randomized control trials or high quality prospective, matched group cohort studies), through December of 2006, relative to the effectiveness of botulinum toxin for treating spasmodic dysphonia. Results of the review indicated that no new high quality (Class I or Class II) studies have been published since 2001. One Class I study has been published since 1973, which found significant treatment effects for acoustic and perceptual variables of vocal function. Four Class II studies have been published during this same time frame, all finding significant treatment effects, though the nature of studied factors was variable between investigations. Based on the quality of evidence scale used, botulinum toxin can be considered an effective treatment for adductor spasmodic dysphonia.

Keywords: Botulinum toxin; spasmodic dysphonia 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams, SG, Hunt, EJ, Irish, JC, Charles, DA, Lang, AE, Durkin, LC, Wong, DLH 1995Comparison of botulinum toxin injection procedures in adductor spasmodic dysphoniaJ Otolaryngol24345351PubMedGoogle Scholar
  2. Ali, S, Thomassen, M, Schulz, G, Hosey, L, Varga, M, Ludlow, C, Braun, A 2006Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: an H2 15O PET studyJ Speech Lang Hear Res4911271146PubMedCrossRefGoogle Scholar
  3. Aronson, A 1990Clinical voice disorders: an interdisciplinary approachThiemeNew YorkGoogle Scholar
  4. Bielamowicz, S, Bidus, K, Squire, S, Ludlow, C 2001Assessment of posterior cricoarytenoid botulinum toxin injections in patients with abductor spasmodic dysphoniaAnn Otol Rhinol Laryngol110406412PubMedGoogle Scholar
  5. Bielamowicz, S, Ludlow, CL 2000Effects of botulinum toxin on pathophysiology in spasmodic dysphoniaAnn Otol Rhinol Laryngol109194203PubMedGoogle Scholar
  6. Blitzer, A, Brin, M, Stewart, C 1998Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patientsLaryngoscope10814351441PubMedCrossRefGoogle Scholar
  7. Blitzer, A, Brin, MF 1991Laryngeal dystonia: a series with botulinum toxin therapyAnn Otol Rhinol Laryngol1008589PubMedGoogle Scholar
  8. Blitzer, A, Sulica, L 2001Botulinum toxin: basic science and clinical uses in otolaryngologyLaryngoscope111218226PubMedCrossRefGoogle Scholar
  9. Brin, M, Blitzer, A, Stewart, C, Diamond, B, Pogoda, J 2001Botulinum toxin type A for adductor spasmodic dysphonia (laryngeal dystonia): double-blind placebo-controlled assessment of dose and techniqueNeurology56A346Google Scholar
  10. Cannito, M 2001

    Neurological aspects of spasmodic dysphonia

    Vogel, DCannito, M eds. Treating disordered speech motor controlPro-EdAustin
    Google Scholar
  11. Cannito, M, Johnson, P 1981Spastic dysphonia: a continuum disorderJ Commun Disord14215223PubMedCrossRefGoogle Scholar
  12. Duffy, J, Yorkston, K 2003Medical interventions for spasmodic dysphonia and some related conditions: a systematic reviewJ Med Speech Pathol11ixlviiiGoogle Scholar
  13. Drost, H, Baatenburg de Jong, R 1998Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphoniaAnn Otol Rhinol Laryngol107280284PubMedGoogle Scholar
  14. Fisher, K, Scherer, R, Swank, P, Giddens, C, Patten, D 1999Electroglottographic tracking of phonatory response to BotoxJ Voice13203209PubMedCrossRefGoogle Scholar
  15. Ford, C, Bless, D, Lowery, J 1990Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphoniaOtolaryngol Head Neck Surg103752758PubMedGoogle Scholar
  16. Ford, C, Bless, D, Patel, N 1992Botulinum toxin treatment of spasmodic dysphonia: techniques, indications, efficacyJ Voice6370376CrossRefGoogle Scholar
  17. Goodin, D, Frohman, E, Garmany, G, Halper, J, Likosky, W, Lublin, F, Silberberg, D, Stuart, W, van den Noort, S 2002Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice GuidelinesNeurology58169178PubMedGoogle Scholar
  18. Green, D, Ward, P, Berke, G, Gerratt, B 1992Point-touch technique of botulinum toxin injection for the treatment of spasmodic dysphoniaAnn Otol Rhinol Laryngol101883887PubMedGoogle Scholar
  19. Haslinger, B, Erhard, P, Dresel, C, Castrop, F, Roettinger, M, Ceballos-Baumann, A 2005“Silent event-related” fMRI reveals reduced sensorimotor activation in laryngeal dystoniaNeurology2215621569CrossRefGoogle Scholar
  20. Hillel, A 2001The study of laryngeal muscle activity in normal human subjects an din patients with laryngeal dystonia using multiple fine-wire electromyographyLaryngoscope111147PubMedCrossRefGoogle Scholar
  21. Hirano, S, Kojima, H, Naito, Y, Tateya, I, Shoji, K, Kaneko, K, Inoue, M, Nishizawa, S, Konishi, J 2001Cortical dysfunction of the supplementary motor area in a spasmodic dysphonia patientAm J Otolaryngol22219222PubMedCrossRefGoogle Scholar
  22. Langeveld, T, Edgar, H, Jeroen, J, Van Rossum, M, Zwinderman, A, Baatenburg, R 2001Evaluation of voice quality in adductor spasmodic dysphonia before and after botulinum toxin treatmentAnn Otol Rhinol Laryngol110627634PubMedGoogle Scholar
  23. Ludlow, C, Bagley, J, Yin, S, Koda, J 1992A comparison of injection techniques using botulinum toxin injection for treatment of the spasmodic dysphoniaJ Voice6380386CrossRefGoogle Scholar
  24. Lundy, D, Ling Lu, F, Casiano, R, Xue, J 1998The effect of patient factors on response outcomes to botox treatment for spasmodic dysphoniaJ Voice4460466CrossRefGoogle Scholar
  25. Maronian, C, Waugh, P, Robinson, L, Hillel, A 2004Tremor laryngeal dystonia: treatment of the lateral cricoarytenoid muscleAnn Otol Rhinol Laryngol113349355PubMedGoogle Scholar
  26. Mehta, R, Goldman, S, Orloff, L 2001Long-term therapy for spasmodic-dysphonia: acoustic and aerodynamic outcomesArch Otolaryngol Head Neck Surg127393399PubMedGoogle Scholar
  27. Papathanasiou, I, MacDonald, L, Whurr, R, Brookes, G, Jahanshahi, M 1997Perceived stigma among patients with spasmodic dysphoniaJ Medic Speech-Language Pathol5251261Google Scholar
  28. Rhew, K, Fiedler, DA, Ludlow, CL 1994Technique for injection of botulinum toxin through the flexible nasolaryngoscopeOtolaryngol Head Neck Surg111787794PubMedCrossRefGoogle Scholar
  29. Rodriguez, A, Ford, C, Bless, D, Harmon, R 1994Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injectionElectromyography Clin Neurophysiol34403407Google Scholar
  30. Sapienza, C, Cannito, M, Murry, T, Branski, R, Woodson, G 2002Acoustic variations in reading produced by speakers with spasmodic dysphonia pre-botox injection and within early stages of post-botox injectionJ Speech Lang Hear Res45830843PubMedCrossRefGoogle Scholar
  31. Schonweiler, R, Wohlfarth, K, Dengler, R, Ptok, M 1998Supraglottal injection of botulinum toxin type A in adductor spasmodic dysphonia with both intrinsic and extrinsic hyperfunctionLaryngoscope1085563PubMedCrossRefGoogle Scholar
  32. Strong, B, DelGaudio, J, Hapner, E, Johns, M 2005Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphoniaArch Otolaryngol Head Neck Surg131793795CrossRefGoogle Scholar
  33. Truong, D, Rontal, M, ROlnick, M, Aronson, A, Mistura, K 1991Double-blind controlled study of botulinum toxin in adductor spasmodic dysphoniaLaryngoscope101630634CrossRefGoogle Scholar
  34. Watts, C, Nye, C, Whurr, R 2006Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane reviewClin Rehabil20112122PubMedCrossRefGoogle Scholar
  35. Wong, D, Irish, J, Adams, S, Durkin, L, Hunt, E 1995Laryngeal image analysis following botulinum toxin injections in spasmodic dysphoniaJ Otolaryngol246468PubMedGoogle Scholar
  36. Whurr, R, Lorch, M, Fontana, H, Brookes, G, Lees, A, Marsden, CD 1993The use of botulinum toxin in the treatment of adductor spasmodic dysphoniaJ Neurol Neurosurg Psychiatry56526530PubMedCrossRefGoogle Scholar
  37. Whurr, R, Lorch, M, Lindsay, M, Brookes, G, Marsden, C 1998Psychological function in spasmodic dysphonia before and after treatment with botulinum toxinJ Med Speech Language Pathol28191Google Scholar
  38. Zwirner, P, Murry, T, Swenson, M, Woodson, GE 1991Acoustic changes in spasmodic dysphonia after botulinum toxin injectionJ Voice57884CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Department of Communication Sciences and DisordersJames Madison UniversityHarrisonbergU.S.A.
  2. 2.The Parkinson’s and Movement Disorder InstituteFountain ValleyU.S.A.
  3. 3.Department of Communicative DisordersUniversity of Central FloridaFloridaU.S.A.

Personalised recommendations